BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1260 related articles for article (PubMed ID: 26759139)

  • 21. Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation.
    Rodrigues P; Marques M; Pimentel S; Rato M; Carvalho P; Correia SC; Mendes N; Amaral H; Fernandes JP; Carvalho MJ; Plancha CE
    J Assist Reprod Genet; 2020 Dec; 37(12):3089-3094. PubMed ID: 33113072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle.
    Cimadomo D; Vaiarelli A; Colamaria S; Trabucco E; Alviggi C; Venturella R; Alviggi E; Carmelo R; Rienzi L; Ubaldi FM
    Hum Reprod; 2018 Aug; 33(8):1442-1448. PubMed ID: 29912374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.
    Puy V; Dupeux M; Mayeur A; Grynberg M; Benoit A; Bendayan M; Zhegari F; Hesters L; Gallot V; Prevot S; Frydman N; Sonigo C
    Hum Reprod; 2023 May; 38(5):860-871. PubMed ID: 36860186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency.
    Gayete-Lafuente S; Turan V; Oktay KH
    J Assist Reprod Genet; 2023 Dec; 40(12):2777-2785. PubMed ID: 37715873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes from ART in predicted hyperresponders: in vitro maturation of oocytes versus conventional ovarian stimulation for IVF/ICSI.
    Mostinckx L; Goyens E; Mackens S; Roelens C; Boudry L; Uvin V; Segers I; Schoemans C; Drakopoulos P; Blockeel C; De Vos M
    Hum Reprod; 2024 Mar; 39(3):586-594. PubMed ID: 38177084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priming Before In Vitro Maturation Cycles in Cancer Patients Undergoing Urgent Fertility Preservation: a Randomized Controlled Study.
    Sonigo C; Le Conte G; Boubaya M; Ohanyan H; Pressé M; El Hachem H; Cedrin-Durnerin I; Benoit A; Sifer C; Sermondade N; Grynberg M
    Reprod Sci; 2020 Dec; 27(12):2247-2256. PubMed ID: 32617881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre.
    Simi G; Obino ME; Casarosa E; Litta P; Artini PG; Cela V
    Gynecol Endocrinol; 2015; 31(12):966-70. PubMed ID: 26370262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular flushing increases the number of oocytes retrieved: a randomized controlled trial.
    Lainas GT; Lainas TG; Makris AA; Xenariou MV; Petsas GK; Kolibianakis EM
    Hum Reprod; 2023 Oct; 38(10):1927-1937. PubMed ID: 37632249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of menstrual cycle phase and AMH levels in breast cancer patients whose ovarian tissue was cryopreserved for oncofertility treatment.
    Takae S; Sugishita Y; Yoshioka N; Hoshina M; Horage Y; Sato Y; Nishijima C; Kawamura K; Suzuki N
    J Assist Reprod Genet; 2015 Feb; 32(2):305-12. PubMed ID: 25464895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count.
    Guzman L; Ortega-Hrepich C; Polyzos NP; Anckaert E; Verheyen G; Coucke W; Devroey P; Tournaye H; Smitz J; De Vos M
    Hum Reprod; 2013 May; 28(5):1261-6. PubMed ID: 23427238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of ovarian tissue oocytes from transgender men reveals poor calcium release and embryo development, which might be overcome by spindle transfer.
    Christodoulaki A; He H; Zhou M; Cardona Barberán A; De Roo C; Chuva De Sousa Lopes SM; Baetens M; Menten B; Van Soom A; De Sutter P; Weyers S; Boel A; Stoop D; Heindryckx B
    Hum Reprod; 2023 Jun; 38(6):1135-1150. PubMed ID: 37029914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follicular fluid from infertile women with mild endometriosis may compromise the meiotic spindles of bovine metaphase II oocytes.
    Da Broi MG; Malvezzi H; Paz CC; Ferriani RA; Navarro PA
    Hum Reprod; 2014 Feb; 29(2):315-23. PubMed ID: 24166595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients.
    Demirtas E; Elizur SE; Holzer H; Gidoni Y; Son WY; Chian RC; Tan SL
    Reprod Biomed Online; 2008 Oct; 17(4):520-3. PubMed ID: 18854106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
    Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
    Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elective and Onco-fertility preservation: factors related to IVF outcomes.
    Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
    Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation.
    Oktay K; Buyuk E; Rodriguez-Wallberg KA; Sahin G
    Reprod Biomed Online; 2010 May; 20(5):634-8. PubMed ID: 20219430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation.
    Maman E; Meirow D; Brengauz M; Raanani H; Dor J; Hourvitz A
    Fertil Steril; 2011 Jan; 95(1):64-7. PubMed ID: 20688325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.